Literature DB >> 18466289

Association between low thigh fat and non-alcoholic fatty liver disease.

Dae Won Jun1, Jee Hye Han, Sang Heum Kim, Eun Chul Jang, Nam In Kim, Jun Seok Lee, Moon Hee Song, Seung Hwan Kim, Yoon Ju Jo, Young Sook Park.   

Abstract

BACKGROUND AND AIM: Some people have a fatty liver despite having low visceral fat and a low body mass index (BMI). We investigated whether fat distribution, especially thigh subcutaneous fat and thigh intramuscular fat, is associated with non-alcoholic fatty liver disease (NAFLD).
METHODS: The patients consisted of 408 men and women. NAFLD was defined by an ultrasound scan and excluded other liver diseases. Visceral, subcutaneous abdominal, intramuscular, and subcutaneous thigh adipose tissue was measured by computed tomography.
RESULTS: The frequency of NAFLD decreased over a quartile of thigh fat independently of BMI in the female patients. Additional adjustments for age and visceral fat area did not change the results. This finding was not observed in the male patients. To investigate the relationship between each fat distribution and NAFLD, we performed a logistic regression analysis. Fat distribution was divided into four groups: visceral fat, abdominal subcutaneous fat, thigh subcutaneous fat, and thigh intramuscular fat. All four fat components were chosen as variables for the regression model. Age, BMI, and the homeostasis model assessment (HOMA) index were then adjusted successively. A larger subcutaneous fat area was negatively associated with NAFLD after adjustment for visceral fat and abdominal subcutaneous fat areas in women, but not in men. It did not change even after age adjustment, BMI, and the HOMA index.
CONCLUSION: Low femoral subcutaneous fat amounts were shown to be independently associated with fatty liver disease in women. These results show the importance of accurate measurements of other regional body compositions as well as visceral fat amounts when investigating NAFLD.

Entities:  

Mesh:

Year:  2008        PMID: 18466289     DOI: 10.1111/j.1440-1746.2008.05330.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  10 in total

1.  Regional anthropometric measures and hepatic fibrosis in patients with nonalcoholic Fatty liver disease.

Authors:  Ayako Suzuki; Manal F Abdelmalek; Aynur Unalp-Arida; Katherine Yates; Arun Sanyal; Cynthia Guy; Anna Mae Diehl
Journal:  Clin Gastroenterol Hepatol       Date:  2010-08-20       Impact factor: 11.382

2.  Trunk fat is associated with increased serum levels of alanine aminotransferase in the United States.

Authors:  Constance E Ruhl; James E Everhart
Journal:  Gastroenterology       Date:  2010-01-11       Impact factor: 22.682

3.  Relationship between Neck Circumference and Non-Alcoholic Fatty Liver Disease in Childhood Obesity.

Authors:  Nihal Hatipoğlu; Serap Doğan; M Mümtaz Mazıcıoğlu; Selim Kurtoğlu
Journal:  J Clin Res Pediatr Endocrinol       Date:  2015-12-18

4.  The Angiogenesis Inhibitor ALS-L1023 from Lemon-Balm Leaves Attenuates High-Fat Diet-Induced Nonalcoholic Fatty Liver Disease through Regulating the Visceral Adipose-Tissue Function.

Authors:  Jeongjun Kim; Haerim Lee; Jonghoon Lim; Jaeho Oh; Soon Shik Shin; Michung Yoon
Journal:  Int J Mol Sci       Date:  2017-04-17       Impact factor: 5.923

5.  The visceral fat area to leg muscle mass ratio is significantly associated with the risk of hyperuricemia among women: a cross-sectional study.

Authors:  Xiao-He Wang; Wei-Ran Jiang; Min-Ying Zhang; Ying-Xin Shi; Yun-Ping Ji; Chun-Jun Li; Jing-Na Lin
Journal:  Biol Sex Differ       Date:  2021-01-29       Impact factor: 5.027

6.  Ascorbic acid inhibits visceral obesity and nonalcoholic fatty liver disease by activating peroxisome proliferator-activated receptor α in high-fat-diet-fed C57BL/6J mice.

Authors:  Hyunghee Lee; Jiwon Ahn; Soon Shik Shin; Michung Yoon
Journal:  Int J Obes (Lond)       Date:  2018-10-03       Impact factor: 5.095

7.  Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively?

Authors:  Giovanni Tarantino; Patrizia Colicchio; Paolo Conca; Carmine Finelli; Matteo Nicola Dario Di Minno; Marianna Tarantino; Domenico Capone; Fabrizio Pasanisi
Journal:  J Inflamm (Lond)       Date:  2009-03-16       Impact factor: 4.981

8.  Body Composition and Genetic Lipodystrophy Risk Score Associate With Nonalcoholic Fatty Liver Disease and Liver Fibrosis.

Authors:  Vincent L Chen; Andrew P Wright; Brian Halligan; Yanhua Chen; Xiaomeng Du; Samuel K Handelman; Michelle T Long; Douglas P Kiel; Elizabeth K Speliotes
Journal:  Hepatol Commun       Date:  2019-06-18

9.  Comparison of Computed Tomography-based Abdominal Adiposity Indexes as Predictors of Non-alcoholic Fatty Liver Disease Among Middle-aged Korean Men and Women.

Authors:  Jongmin Baek; Sun Jae Jung; Jee-Seon Shim; Yong Woo Jeon; Eunsun Seo; Hyeon Chang Kim
Journal:  J Prev Med Public Health       Date:  2020-06-18

10.  Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.

Authors:  Su Jong Yu; Won Kim; Donghee Kim; Jung-Hwan Yoon; Kyoungbun Lee; Jung Ho Kim; Eun Ju Cho; Jeong-Hoon Lee; Hwi Young Kim; Yoon Jun Kim; Chung Yong Kim
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.